Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma

Clinical and Experimental Allergy

Volumn 44, Issue 1, 2014, Pages 47-57

  Gunawardhana, L P ^a,b   Gibson, P G ^a,b,c   Simpson, J L ^a,b   Powell, H ^a,b   Baines, K J ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Asthma; HAT; HDAC; Inflammatory phenotypes; Monocytes; Sputum

Indexed keywords

ACYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; LYSINE ACETYLTRANSFERASE 2B; NUCLEAR PROTEIN; RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CELL COUNT; CELL ISOLATION; CELL SEPARATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; EOSINOPHIL; EOSINOPHILIC ASTHMA; FEMALE; GENE EXPRESSION; HUMAN; HYPOTHESIS; IMMUNOMAGNETIC SEPARATION; INFLAMMATORY CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHILIC ASTHMA; PAUCIGRANULOCYTIC ASTHMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SPUTUM LEVEL;

ASTHMA; HAT; HDAC; INFLAMMATORY PHENOTYPES; MONOCYTES; SPUTUM;

ADULT; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CASE-CONTROL STUDIES; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 84890826800     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12168     Document Type: Article

References (43)

1. Traister RS, Wenzel SE. Inflammatory phenotypes in asthma pathogenesis. Drug Discovery Today: Disease Mechanisms 2012; 9:e75-e81.
2. McGrath KW, Icitovic N, Boushey HA et al. A large subgroup of mild-to-moderate asthma is persistently non-eosinophilic. Am J Respir Crit Care Med 2012; 185:612-9.
3. Haldar P, Pavord ID, Shaw DE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-24.
4. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma. Chest 2001; 119:1329-36.
5. Baines KJ, Simpson JL, Wood LG, Scott RJ, Gibson PG. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 2011; 127:153-60, e9.
6. Woodruff PG, Modrek B, Choy DF et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180:388-95.
7. Baines KJ, Simpson JL, Bowden NA, Scott RJ, Gibson PG. Differential gene expression and cytokine production from neutrophils in asthma phenotypes. Eur Respir J 2010; 35:522-31.
8. Basyigit I, Yildiz F, Ozkara SK, Boyaci H, Ilgazli A. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Mediators Inflamm 2004; 13:285-91.
9. Kuo M-H, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 1998; 20:615-26.
10. Ito K, Ito M, Elliott WM et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352:1967-76.
11. Ito K, Caramori G, Lim S et al. Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med 2002; 166:392-6.
12. Cosio BG, Mann B, Ito K et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med 2004; 170:141-7.
13. Hew M, Bhavsar P, Torrego A et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006; 174:134-41.
14. Su R-C, Becker AB, Kozyrskyj AL, HayGlass KT. Altered epigenetic regulation and increasing severity of bronchial hyperresponsiveness in atopic asthmatic children. J Allergy Clin Immunol 2009; 124:1116-8.
15. Ito K, Herbert C, Siegle JS et al. Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am J Respir Cell Mol Biol 2008; 39:543-50.
16. Juniper E, O'Byrne P, Guyatt G, Ferrie P, King D. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-7.
17. Gibson P, Wlodarczyk J, Hensley M et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med 1998; 158:36-41.
18. Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010; 79:147-51.
19. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11: 54-61.
20. Osoata GO, Yamamura S, Ito M et al. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem Biophys Res Commun 2009; 384:366-71.
21. Wood LG, Gibson PG. Reduced circulating antioxidant defences are associated with airway hyper-responsiveness, poor control and severe disease pattern in asthma. Br J Nutr 2010; 103:735-41.
22. Baines KJ, Wood LG, Gibson PG. The Nutrigenomics of asthma: molecular mechanisms of airway neutrophilia following dietary antioxidant withdrawal. OMICS 2009; 13:355-65.
23. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15:1110-2.
24. Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004; 200:689-95.
25. Footitt JIM, Mallia P, Trujillo-Torralbo MB, Durham A, Adcock IM, Johnston SL. S14Histone deacetylase activity is reduced in COPD subjects during rhinovirus induced exacerbations. Thorax 2011; 66:A9-10.
26. Tomita K, Barnes PJ, Adcock IM. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 2003; 301:572-7.
27. Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G. The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 1999; 274:32091-8.
28. Winkler AR, Nocka KN, Williams CMM. Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production. Pulm Pharmacol Ther 2012; 25:286-92.
29. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007; 62:211-8.
30. Simpson JL, Gibson PG, Yang IA et al. Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy 2013; 43:29-35.
31. Baines KJ, Simpson JL, Wood LG, Scott RJ, Gibson PG. Systemic upregulation of neutrophil α-defensins and serine proteases in neutrophilic asthma. Thorax 2011; 66:942-7.
32. Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012; 142:86-93.
33. Lakshminarayanan V, Drab-Weiss EA, Roebuck KA. H2O2 and tumor necrosis factor-α induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 1998; 273:32670-8.
34. Ashburner BP, Westerheide SD, Baldwin AS. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001; 21:7065-77.
35. Mroz RM NJ, Chyczewska E, Braszko JJ, Holownia A. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J Physiol Pharmacol 2007; 2007:453-60.
36. Chen L-f, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 2001; 293:1653-7.
37. Yi C, Yu L. How does acetylation regulate autophagy? Autophagy 2012; 8:1529-30.
38. Lee KS, Lee HK, Hayflick JS, Lee YC, Puri KD. Inhibition of phosphoinositide 3-kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 2006; 20:455-65.
39. Duan W, Aguinaldo Datiles AMK, Leung BP, Vlahos CJ, Wong WSF. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 2005; 5:495-502.
40. Jang H-Y, Kwon O-K, Oh S-R, Lee H-K, Ahn K-S, Chin Y-W. Mangosteen xanthones mitigate ovalbumin-induced airway inflammation in a mouse model of asthma. Food Chem Toxicol 2012; 50:4042-50.
41. Lee YC. The role of PTEN in allergic inflammation. Arch Immunol Ther Exp 2004; 52:250-4.
42. Okumura K, Mendoza M, Bachoo RM, DePinho RA, Cavenee WK, Furnari FB. PCAF modulates PTEN activity. J Biol Chem 2006; 281:26562-8.
43. Vergne I, Roberts E, Elmaoued RA et al. Control of autophagy initiation by phosphoinositide 3-phosphatase jumpy. EMBO J 2009; 28:2244-58.